Pfizer Says COVID-19 Vaccine Found Effective In Teens, Will
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
BioNTech-Pfizer said their covid-19 vaccine showed 100% efficacy and robust antibody responses against the coronavirus in 12 to 15-year-olds, as they eye approval for adolescents to get the jabs before the next school year. We plan to submit these data to (US regulator) FDA as a proposed amendment to our Emergency Use Authorisation in the coming weeks and to other regulators around the world," said Pfizer chief executive Albert Bourla.

"Across the globe, we are longing for a normal life. This is especially true for our children," says Ugur Sahin, CEO and Co-founder of BioNTech. "It is very important to enable them to get back to everyday school life," he says. The trial enrolled 2,260 adolescents 12 to 15 years of age in the United States. In the trial, 18 cases of COVID-19 were observed in the placebo group versus none in the vaccinated group.

Vaccination with BNT162b2 elicited SARS-CoV-2–neutralizing antibody geometric mean titers (GMTs) of 1,239.5, demonstrating strong immunogenicity in a subset of adolescents one month after the second dose. This compares well to GMTs elicited by participants aged 16 to 25 years old in an earlier analysis. Further, BNT162b2 administration was well tolerated, with side effects generally consistent with those observed in participants 16 to 25 years of age.

The companies plan to submit these data to the FDA and EMA for a requested amendment to the Emergency Use Authorization of BNT162b2 and the EU Conditional Marketing Authorization for COMIRNATY® to expand use in adolescents 12-15 years of age as quickly as possible. All participants in the trial will continue to be monitored for long-term protection and safety for an additional two years after their second dose.

Source:
https://www.livemint.com/science/health/pfizer-covid-19-vaccine-100-effective-in-teens-shows-trial-11617188288816.html
Dr. T●●●●z H●●●●●●i and 1 others like this
Like
Comment
Share